Description of Research Expertise:
My research focuses on the utilization, development, and validation of tests for the Clinical Microbiology Laboratory at HUP. My two major focuses are on using new technologies such as MALDI-TOF to identify resistant bacteria sooner and the development and utilization of molecular tests to detect viral illnesses.
Glaser L, Andreacchio K, Lyons M, and Alby K: Improved surveillance for carbapenem resistant Enterobacteriaceae using chromogenic media with a broth enrichment Diagnostic Microbiology and Infectious Disease 82 (4): 284-5,2015.
Tran A, Alby K, Kerr A, Jones M, Gilligan PH: Cost Savings Incurred by Implementation of Routine Microbiological Identification by Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry Journal of Clinical Microbiology 53 (8): 2473-9,2015.
Roshdy DG, Tran A, LeCroy N, Zeng D, Ou FS, Daniels LM, Weber DJ, Alby K and Miller MB: Impact of a rapid microarray assay for identification of positive blood cultures on treatment optimization for patients with streptococcal and enterococcal bacteremia Journal of Clinical Microbiology 53 (4): 1411-4,2015.
Chambers BS, Parkhouse K, Ross TM, Alby K, and Hensley SE: Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season Cell Reports 12 (1): 1-6,2015.
Alby K, Glaser LJ, and Edelstein PH: Kocuria rhizophila bacteremia misidentified as Corynebacterium jeikeium and other errors by the VITEK MS call for maintained microbiological competence in the MALDI-TOF era Journal of Clinical Microbiology 53 (1): 360-1,2015.
Cardenas AM, Edelstein PH, and Alby K: Development and Optimization of a Real Time PCR Assay for the Detection of Herpes simplex and Varicella zoster viruses in Skin and Mucosal Lesions Using the BD MAX Open System Journal of Clinical Microbiology 52 (12): 4375-6,2014.
Nicolsen NC, LeCroy N, Alby K, Martin KE, Laux J, Lin FC, Daniels L, Weber DJ, Miller MB: Clinical outcomes with rapid detection of methicillin-resistant and methicillin- susceptible Staphylococcus aureus from routine blood cultures. Journal of Clinical Microbiology 51 (12): 4126-9,2013.
Alby K, Gilligan PH, Miller MB: Comparison of MALDI-TOF Mass Spectrometry Platforms for the Identification of Gram Negative Rods from Cystic Fibrosis Patients. Journal of Clinical Microbiology 51 (11): 3852-4,2013.
Alby K, Daniels LM, Weber DJ, Miller MB: Development of a Treatment Algorithm for Streptococci/Enterococci from Positive Blood Cultures Identified with the Verigene BC-GP Assay. Journal of Clinical Microbiology 51 (11): 3869-71,2013.
Alby, K., Popowitch, E.P., and Miller M.B: Comparative evaluation of the Nanosphere Verigene RV+ Assay with the Simplexa Flu A/B & RSV Kit for the detection of influenza and respiratory syncytial viruses Journal of Clinical Microbiology 51 (1): 352-53,2013.